Literature DB >> 9317072

Viral gastroparesis: a subgroup of idiopathic gastroparesis--clinical characteristics and long-term outcomes.

L P Bityutskiy1, I Soykan, R W McCallum.   

Abstract

OBJECTIVES: Viral gastroparesis has been regarded as a subgroup of idiopathic gastroparesis.
METHODS: We have reviewed the medical records of 143 patients diagnosed as having gastroparesis. Fifty-two patients were regarded as idiopathic in origin, of which 12 were identified as consistent with a postviral etiology. Their follow-up and current status were assessed by interview. Available for interview were 32 patients: 11 from the viral group and 21 from idiopathic group.
RESULTS: All "viral gastroparesis" patients reported gradual improvement of their symptoms, no hospitalizations during the previous 6 months, stable weight, were not disabled, and remained professionally active. In comparison, 21 "idiopathic" patients had an indolent, slowly progressive clinical presentation. The idiopathic group had a significantly longer duration of illness (p < 0.05) with greater symptom score of abdominal pain, early satiety, and anorexia, and overall worse quality of life (p < 0.05).
CONCLUSIONS: A viral etiology should be considered in gastroparesis patients when their illness is characterized by an acute onset, initial severe illness and slow resolution toward a satisfactory quality of life. Idiopathic gastroparesis is a more slowly progressive illness, and patients remain significantly more symptomatic for a longer period of time.

Entities:  

Mesh:

Year:  1997        PMID: 9317072

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  46 in total

Review 1.  Chronic vomiting in children: new insights into diagnosis.

Authors:  S Khan; C Di Lorenzo
Journal:  Curr Gastroenterol Rep       Date:  2001-06

2.  Impairment of gastric nitrergic and NRF2 system in apolipoprotein E knockout mice.

Authors:  Kalpana Ravella; Hong Yang; Pandu R R Gangula
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

3.  Outcomes and Factors Associated With Reduced Symptoms in Patients With Gastroparesis.

Authors:  Pankaj J Pasricha; Katherine P Yates; Linda Nguyen; John Clarke; Thomas L Abell; Gianrico Farrugia; William L Hasler; Kenneth L Koch; William J Snape; Richard W McCallum; Irene Sarosiek; James Tonascia; Laura A Miriel; Linda Lee; Frank Hamilton; Henry P Parkman
Journal:  Gastroenterology       Date:  2015-08-21       Impact factor: 22.682

4.  Severe isolated myopathic gastroparesis: a case report with pathological findings.

Authors:  H Sokol; A Lavergne-Slove; J Mikol; J M Sabate; B Coffin
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

5.  Loss of interstitial cells of Cajal network in severe idiopathic gastroparesis.

Authors:  Edda Battaglia; Gabrio Bassotti; Graziella Bellone; Luca Dughera; Anna-Maria Serra; Luigi Chiusa; Alessandro Repici; Pierroberto Mioli; Giorgio Emanuelli
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

Review 6.  Idiopathic gastroparesis.

Authors:  Henry P Parkman
Journal:  Gastroenterol Clin North Am       Date:  2014-12-24       Impact factor: 3.806

Review 7.  Treatment options for patients with severe gastroparesis.

Authors:  Hasse Abrahamsson
Journal:  Gut       Date:  2007-06       Impact factor: 23.059

Review 8.  Gastroparesis--current concepts and considerations.

Authors:  William L Hasler
Journal:  Medscape J Med       Date:  2008-01-23

Review 9.  Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting.

Authors:  H P Parkman; M Camilleri; G Farrugia; R W McCallum; A E Bharucha; E A Mayer; J F Tack; R Spiller; M Horowitz; A I Vinik; J J Galligan; P J Pasricha; B Kuo; L A Szarka; L Marciani; K Jones; C R Parrish; P Sandroni; T Abell; T Ordog; W Hasler; K L Koch; K Sanders; N J Norton; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2009-12-09       Impact factor: 3.598

Review 10.  Gastroparesis: pathogenesis, diagnosis and management.

Authors:  William L Hasler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-19       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.